Cargando…

Respiratory surveillance for coal mine dust and artificial stone exposed workers in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*

Coal mine lung dust disease (CMDLD) and artificial stone (AS) silicosis are preventable diseases which have occurred in serious outbreaks in Australia recently. This has prompted a TSANZ review of Australia's approach to respiratory periodic health surveillance. While regulating respirable dust...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perret, Jennifer L., Miles, Susan, Brims, Fraser, Newbigin, Katrina, Davidson, Maggie, Jersmann, Hubertus, Edwards, Adrienne, Zosky, Graeme, Frankel, Anthony, Johnson, Anthony R., Hoy, Ryan, Reid, David W., Musk, A. William, Abramson, Michael J., Edwards, Bob, Cohen, Robert, Yates, Deborah H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Position Statements
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702073/ https://www.ncbi.nlm.nih.gov/pubmed/33051927 http://dx.doi.org/10.1111/resp.13952

Ejemplares similares

Work‐related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia
por: Hoy, Ryan, et al.
Publicado: (2020)

Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*
por: Jee, Adelle S., et al.
Publicado: (2020)

Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*
por: McDonald, Christine F., et al.
Publicado: (2020)

Assessing spirometry competence through certification in community‐based healthcare settings in Australia and New Zealand: A position paper of the Australian and New Zealand Society of Respiratory Science
por: Schneider, Irene, et al.
Publicado: (2020)

Ventilatory support at home for children: A joint position paper from the Thoracic Society of Australia and New Zealand/Australasian Sleep Association
por: Chawla, Jasneek, et al.
Publicado: (2021)

Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand
por: Blakey, John, et al.
Publicado: (2021)

COVID-19 and Acute Heart Failure: Screening the Critically Ill – A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ)
por: Lal, Sean, et al.
Publicado: (2020)

Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand*
por: Kapur, Nitin, et al.
Publicado: (2020)

Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand*
por: Dummer, Jack, et al.
Publicado: (2020)

Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ)
por: Nicholls, Stephen J., et al.
Publicado: (2020)

Thoracic Society of Australia and New Zealand Position Statement: Respiratory nursing
por: Smith, Sheree M. S., et al.
Publicado: (2022)

Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: ‘Swimming between the flags’
por: Barnett, Adrian, et al.
Publicado: (2022)

Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement
por: Gray, Belinda, et al.
Publicado: (2020)

Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement
por: Arnold, Ruth H., et al.
Publicado: (2020)

Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia During the COVID-19 Pandemic: A Living Document()
por: Kumar, Saurabh, et al.
Publicado: (2020)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID‐19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell
por: Perram, Jacinta, et al.
Publicado: (2023)

Coil embolization for the treatment of peripheral veins:: A position statement of the International Union of Phlebology (UIP), the Australasian College of Phlebology (ACP), the Australia and New Zealand Society for Vascular Surgery (ANZSVS), the American Venous Forum (AVF), the American Vein and Lymphatic Society (AVLS), and the Interventional Radiology Society of Australia (IRSA)
por: Parsi, Kurosh, et al.
Publicado: (2020)

Forests under the Southern Cross: The forest environmental frontier in Australia and New Zealand
por: Kanowski, Peter, et al.
Publicado: (2021)

Australia and New Zealand Dialysis and Transplant Registry
por: McDonald, Stephen P
Publicado: (2015)

Pharmaceutical pricing, cost containment and new treatments for rare diseases in children
por: Stella, Peter, et al.
Publicado: (2014)

New avenues for prevention of occupational cancer: a global policy perspective
por: Iavicoli, Sergio, et al.
Publicado: (2019)

Directions for new developments on statistical design and analysis of small population group trials
por: Hilgers, Ralf-Dieter, et al.
Publicado: (2016)

Sharing is caring: a call for a new era of rare disease research and development
por: Denton, Nathan, et al.
Publicado: (2022)

A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs
por: Cui, Yazhou, et al.
Publicado: (2015)

Australia and New Zealand Health Policy: a new journal
por: Duckett, Stephen J
Publicado: (2004)

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
por: Kourakis, Stephanie, et al.
Publicado: (2021)

Postoperative complications in Australia and New Zealand (the REASON study)
por: Story, David A
Publicado: (2013)

Guide to the Health Resorts in Australia, Tasmania, and New Zealand
Publicado: (1888)

List of Unregistered Medical Practitioners in Australia and New Zealand
Publicado: (1886)

One Health research and training in Australia and New Zealand
por: Reid, Simon A., et al.
Publicado: (2016)

A survey of cariology teaching in Australia and New Zealand
por: Raphael, Sarah L., et al.
Publicado: (2018)

Guide to the Health Resorts in Australia, Tasmania, and New Zealand
Publicado: (1888)

The Benefits of Colorectal Surgery Surveys in Australia and New Zealand
por: Ricardo Hamilton, Auerilius Erastus, et al.
Publicado: (2020)

Equity and diversity in the nephrology workforce in Australia and New Zealand
por: Francis, Anna, et al.
Publicado: (2022)

A Review of Petrol Burns in Australia and New Zealand
por: Savage, Nicholas, et al.
Publicado: (2023)

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
por: Southall, Noel T, et al.
Publicado: (2019)

Clinical development innovation in rare diseases: lessons learned and best practices from the DevelopAKUre consortium
por: Rudebeck, Mattias, et al.
Publicado: (2021)

General practice and the New Zealand health reforms – lessons for Australia?
por: McAvoy, Brian R, et al.
Publicado: (2005)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rvletr8d39aqp6o231j7g6qd58